Xvivo Perfusion AB (XVIVO) — Cash Flow Quality Index
Xvivo Perfusion AB (XVIVO) has a Cash Flow Quality Index of 1.53x as of March 2026. Operating cash flow of Skr65.34 Million exceeds net income of Skr42.83 Million, indicating high earnings quality where cash backs reported profits. Explore XVIVO long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Xvivo Perfusion AB Cash Flow Quality Index (2012–2025)
Historical Cash Flow Quality Index for Xvivo Perfusion AB across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check XVIVO goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Xvivo Perfusion AB (2012–2025)
Year-by-year earnings quality comparison for Xvivo Perfusion AB. For live market cap and the full company financial profile, see market cap of Xvivo Perfusion AB.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.02x | Skr101.07 Million | Skr25.16 Million | ▲ +621.6% |
| 2024 | 0.56x | Skr111.29 Million | Skr199.95 Million | ▲ +10.4% |
| 2023 | 0.50x | Skr46.29 Million | Skr91.82 Million | ▼ -59.6% |
| 2022 | 1.25x | Skr27.86 Million | Skr22.31 Million | ▲ +169.0% |
| 2021 | -1.81x | Skr-12.06 Million | Skr6.67 Million | ▼ -132.4% |
| 2019 | 5.58x | Skr29.50 Million | Skr5.29 Million | ▲ +313.0% |
| 2018 | 1.35x | Skr23.63 Million | Skr17.50 Million | ▼ -54.7% |
| 2017 | 2.98x | Skr22.19 Million | Skr7.45 Million | ▼ -29.0% |
| 2016 | 4.19x | Skr12.55 Million | Skr2.99 Million | ▲ +261.6% |
| 2015 | 1.16x | Skr8.58 Million | Skr7.40 Million | ▲ +308.2% |
| 2014 | -0.56x | Skr-3.74 Million | Skr6.72 Million | ▼ -144.3% |
| 2013 | 1.26x | Skr13.46 Million | Skr10.72 Million | ▼ -89.5% |
| 2012 | 12.01x | Skr1.67 Million | Skr139.00K | — |